Despite improvements in antirejection therapies, solid organ transplantation is hampered by chronic rejection, with around 70% of transplants being rejected within 10 years post-transplantation. Given the growing number of transplant candidates and the shortage of organ donors, finding a cure for chronic rejection is a priority in transplantation. Although chronic rejection studies have increased our knowledge of the subject over the years, the cellular and molecular processes involved in chronic rejection are still not fully understood.
This volume covers the molecular and cellular aspects of the chronic rejection of both solid and composite allografts. It is divided into three parts:
The book provides a comprehensive overview of the mechanisms and challenges involved, with the aim of inspiring the development of new therapies for chronic rejection.
Les informations fournies dans la section « Synopsis » peuvent faire référence à une autre édition de ce titre.
Malgorzata Kloc: Prior to completing her postdoctoral training in Canada, Dr. Kloc was a tenured Associate Professor in the Department of Zoology at the University of Warsaw, Poland. She also served as a Research Associate in the Department of Biology at Carleton University in Ottawa, Canada. While completing her postdoctoral training, Dr. Kloc earned the AHFMR Research Award from the University of Calgary and the MRC Biotechnology Training Award from Dalhousie University. She joined the University of Texas M.D. Anderson Cancer Center as a Research Scientist in the Department of Molecular Genetics in 1987, and became an Associate Professor in the Department of Biochemistry and Molecular Biology there in 2006. Dr. Kloc joined the Houston Methodist Research Institute in 2008. Currently, Dr. Kloc is the Weill Cornell Professor of Cell and Molecular Biology at The Houston Methodist Hospital.
Rafik Mark Ghobrial is a Professor of Surgery at Weill Cornell Medical College, Director of the J.C. Walter Jr. Transplant Center, Houston Methodist, Houston, Texas, and he holds the J.C. Walter Jr. Presidential Distinguished Chair. He obtained his MD from Cairo University and PhD from the University of Texas Health Science Center, Houston, Texas. His medical training was completed at Massachusetts General Hospital, University of Texas Health Science Center, and the University of California, Los Angeles (UCLA). He is the recipient of multiple awards and honors and was elected to the Fellowship of The Royal College of Surgeons-Edinburgh and the American Surgical Association. As a researcher, he is the recipient of multiple grants and has held NIH sponsored awards in transplant immunology and clinical sciences. He has authored nearly 300 articles, chapters and has lectured widely, both nationally and internationally, on topics related to liver disease and transplantation. Dr. Ghobrial has served on numerous committees and held multiple advisory and leadership roles and is currently the President of the International Liver Transplant Society.
Les informations fournies dans la section « A propos du livre » peuvent faire référence à une autre édition de ce titre.
Vendeur : Brook Bookstore On Demand, Napoli, NA, Italie
Etat : new. Questo è un articolo print on demand. N° de réf. du vendeur 0HXHXZAFDP
Quantité disponible : Plus de 20 disponibles
Vendeur : Basi6 International, Irving, TX, Etats-Unis
Etat : Brand New. New. Delivery takes 20-25 days. Print on Demand. N° de réf. du vendeur POD-411147
Quantité disponible : 10 disponible(s)
Vendeur : Books From California, Simi Valley, CA, Etats-Unis
hardcover. Etat : Very Good. N° de réf. du vendeur mon0004190035
Quantité disponible : 1 disponible(s)
Vendeur : BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Allemagne
Buch. Etat : Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Despite improvements in antirejection therapies, solid organ transplantation is hampered by chronic rejection, with around 70% of transplants being rejected within 10 years post-transplantation. Given the growing number of transplant candidates and the shortage of organ donors, finding a cure for chronic rejection is a priority in transplantation. Although chronic rejection studies have increased our knowledge of the subject over the years, the cellular and molecular processes involved in chronic rejection are still not fully understood.This volume covers the molecular and cellular aspects of the chronic rejection of both solid and composite allografts. It is divided into three parts:Part I provides a comprehensive overview and mechanistic understanding of the cellular and molecular pathways underlying chronic rejection, as well as their potential in identifying novel biomarkers and developing targeted anti-chronic rejection strategies.Part II focuses on immune cells, non-immune cells, and extracellular molecules in the context of chronic rejection.Part III concentrates on shared and organ-specific (liver, face, kidney, lung) features as well as the latest therapeutic approaches in chronic rejection.The book provides a comprehensive overview of the mechanisms and challenges involved, with the aim of inspiring the development of new therapies for chronic rejection. 273 pp. Englisch. N° de réf. du vendeur 9783032076854
Quantité disponible : 2 disponible(s)
Vendeur : Grand Eagle Retail, Bensenville, IL, Etats-Unis
Hardcover. Etat : new. Hardcover. Despite improvements in antirejection therapies, solid organ transplantation is hampered by chronic rejection, with around 70% of transplants being rejected within 10 years post-transplantation. Given the growing number of transplant candidates and the shortage of organ donors, finding a cure for chronic rejection is a priority in transplantation. Although chronic rejection studies have increased our knowledge of the subject over the years, the cellular and molecular processes involved in chronic rejection are still not fully understood.This volume covers the molecular and cellular aspects of the chronic rejection of both solid and composite allografts. It is divided into three parts:Part I provides a comprehensive overview and mechanistic understanding of the cellular and molecular pathways underlying chronic rejection, as well as their potential in identifying novel biomarkers and developing targeted anti-chronic rejection strategies.Part II focuses on immune cells, non-immune cells, and extracellular molecules in the context of chronic rejection.Part III concentrates on shared and organ-specific (liver, face, kidney, lung) features as well as the latest therapeutic approaches in chronic rejection.The book provides a comprehensive overview of the mechanisms and challenges involved, with the aim of inspiring the development of new therapies for chronic rejection. Shipping may be from multiple locations in the US or from the UK, depending on stock availability. N° de réf. du vendeur 9783032076854
Quantité disponible : 1 disponible(s)
Vendeur : preigu, Osnabrück, Allemagne
Buch. Etat : Neu. Cellular and Molecular Mechanisms of Chronic Rejection in Organ Transplantation | Malgorzata Kloc (u. a.) | Buch | Results and Problems in Cell Differentiation | viii | Englisch | 2026 | Springer | EAN 9783032076854 | Verantwortliche Person für die EU: Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg, juergen[dot]hartmann[at]springer[dot]com | Anbieter: preigu Print on Demand. N° de réf. du vendeur 134503387
Quantité disponible : 5 disponible(s)
Vendeur : buchversandmimpf2000, Emtmannsberg, BAYE, Allemagne
Buch. Etat : Neu. This item is printed on demand - Print on Demand Titel. Neuware -Despite improvements in antirejection therapies, solid organ transplantation is hampered by chronic rejection, with around 70% of transplants being rejected within 10 years post-transplantation. Given the growing number of transplant candidates and the shortage of organ donors, finding a cure for chronic rejection is a priority in transplantation. Although chronic rejection studies have increased our knowledge of the subject over the years, the cellular and molecular processes involved in chronic rejection are still not fully understood.Springer-Verlag KG, Sachsenplatz 4-6, 1201 Wien 284 pp. Englisch. N° de réf. du vendeur 9783032076854
Quantité disponible : 1 disponible(s)
Vendeur : AHA-BUCH GmbH, Einbeck, Allemagne
Buch. Etat : Neu. Druck auf Anfrage Neuware - Printed after ordering - Despite improvements in antirejection therapies, solid organ transplantation is hampered by chronic rejection, with around 70% of transplants being rejected within 10 years post-transplantation. Given the growing number of transplant candidates and the shortage of organ donors, finding a cure for chronic rejection is a priority in transplantation. Although chronic rejection studies have increased our knowledge of the subject over the years, the cellular and molecular processes involved in chronic rejection are still not fully understood.This volume covers the molecular and cellular aspects of the chronic rejection of both solid and composite allografts. It is divided into three parts:Part I provides a comprehensive overview and mechanistic understanding of the cellular and molecular pathways underlying chronic rejection, as well as their potential in identifying novel biomarkers and developing targeted anti-chronic rejection strategies.Part II focuses on immune cells, non-immune cells, and extracellular molecules in the context of chronic rejection.Part III concentrates on shared and organ-specific (liver, face, kidney, lung) features as well as the latest therapeutic approaches in chronic rejection.The book provides a comprehensive overview of the mechanisms and challenges involved, with the aim of inspiring the development of new therapies for chronic rejection. N° de réf. du vendeur 9783032076854
Quantité disponible : 1 disponible(s)
Vendeur : Books Puddle, New York, NY, Etats-Unis
Etat : New. N° de réf. du vendeur 26404833467
Quantité disponible : 4 disponible(s)
Vendeur : Majestic Books, Hounslow, Royaume-Uni
Etat : New. Print on Demand. N° de réf. du vendeur 408353636
Quantité disponible : 4 disponible(s)